Global Efavirenz Market Research Report 2024, Forecast to 2029
Exclusive deal : 20% Instant discount on Direct purchases! Don't wait—claim your discount today!
Efavirenz is used along with other medications to treat human immunodeficiency virus (HIV) infection. Efavirenz is in a class of medications called non-nucleoside reverse transcriptase inhibitors (NNRTIs). It works by decreasing the amount of HIV in the blood.
Our market research covers global as well as regional markets and provides an in-depth analysis of the overall growth prospects of the market. Global market trend analysis including historical data, estimates to 2024, and compound annual growth rate (CAGR) forecast to 2029 is given based on qualitative and quantitative analysis of the market segments involving economic and non-economic factors. Furthermore, it reveals the comprehensive competitive landscape of the global market, the current and future market prospects of the industry, and the growth opportunities and drivers as well as challenges and constraints in emerging and emerging markets.
We can meet the customized needs of customers in multiple dimensions, in-depth and high quality, help customers accurately grasp market opportunities, easily deal with market challenges, properly formulate market strategies, and act quickly to win sufficient market competition time and space for customers.
Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation.
The global economy and markets have been remarkably resilient in the face of tightening financial conditions and geopolitical upheaval over the past few years, with economic growth holding up better than most analysts’ expectations.
The global environment has still not settled onto a clear pathway toward a new stability as we enter 2024. In this disjointed world, we confront risks posed by potential volatility across the economic and political spheres. We also see potential opportunities arising from the new reality of greatly segmented global relationships.
We have identified five overlapping themes that will drive global political and economic relationships in 2024: geopolitical reordering, economic fault lines, resource security, supply chain resilience and logistics rewired.
The report will conduct a comprehensive and professional analysis of the Efavirenz market in 2024 based on the current situation, global economic impact and other aspects.
Market Segment by Product Type
10 Tables
30 Tables
Market Segment by Product Application
Hospital
Clinic
Drug Center
Other
Finally, the report provides detailed profile and data information analysis of leading company.
Gilead Sciences
Cipla
Emcure Pharmaceuticals
Mylan Pharmaceuticals
Sun Pharmaceutical Industries
Veritaz Healthcare
Alkem Laboratories
Insights and Tools:
This report provides industry-standard analytical accuracy and high data completeness to uncover key opportunities available in the global industry market. Buyers of the report can obtain verified and reliable market forecasts, including revenue forecasts for the overall size of the global industry market.
The report is an effective tool for players to gain a competitive advantage over their competitors and ensure lasting success in the industry market. All findings, data, and information presented in the report have been verified and re-verified with the help of reliable sources. The analysts who authored the report have taken a unique approach to industry-best research and analysis for an in-depth study of the global industry market.
Use both primary and secondary data sources when compiling reports. Primary sources include extensive interviews with key opinion leaders and industry experts such as experienced front-line employees, directors, CEOs and marketing executives, downstream distributors as well as end users. Secondary sources include research on top companies' annual and financial reports, public documents, new journals, and more. We also work with some third-party databases.
The market research includes historical and forecast data from like demand, application details, price trends, and company shares by geography, especially focuses on the key regions like United States, European Union, China, and other regions.
Research Objectives
1.To define, describe and forecast the Efavirenz market by type, application, end user and region
2.Provide enterprise external environment analysis and SWOT analysis
3.Focuses on the key global Efavirenz manufacturers, to define, describe and analyze the value, market share, market competition landscape, Porter's five forces analysis, and development plans in next few years.
4.Provide market entry strategy analysis for new players or players preparing to enter the market
5.Keep up with international market trends and analyze the impact of the important international events on major global regions
6.Analyze market opportunities for stakeholders to provide market leaders with detailed information on the competitive landscape
Global Efavirenz Market Research Report 2024, Forecast to 2029
1 Market Study Overview
1.1 Study Objectives
1.2 Efavirenz Introduce
1.3 Combined with the Analysis of Macroeconomic Indicators
1.4 Brief Description of Research methods
1.5 Market Breakdown and Data Triangulation
2 Global Trend Summary
2.1 Efavirenz Segment by Type
2.1.1 10 Tables
2.1.2 30 Tables
2.2 Market Analysis by Application
2.2.1 Hospital
2.2.2 Clinic
2.2.3 Drug Center
2.2.4 Other
2.3 Global Efavirenz Market Comparison by Regions (2019-2029)
2.3.1 Global Efavirenz Market Size (2019-2029)
2.3.2 North America Efavirenz Status and Prospect (2019-2029)
2.3.3 Europe Efavirenz Status and Prospect (2019-2029)
2.3.4 China Efavirenz Status and Prospect (2019-2029)
2.3.5 Japan Efavirenz Status and Prospect (2019-2029)
2.3.6 Southeast Asia Efavirenz Status and Prospect (2019-2029)
2.4 Basic Product Information
2.4.1 Basic Product Information & Technology Development History
2.4.2 Product Manufacturing Process
2.4.3 Interview with Major Market Participants
2.4.4 High-end Market Analysis and Forecast
2.5 Coronavirus Disease 2020 (Covid-19): Efavirenz Industry Impact
2.5.1 Efavirenz Business Impact Assessment - Covid-19
2.5.2 Market Trends and Efavirenz Potential Opportunities in the COVID-19 Landscape
2.5.3 Measures / Proposal against Covid-19
3 Competition by Manufacturer
3.1 Global Efavirenz Sales and Market Share by Manufacturer (2019-2024)
3.2 Global Efavirenz Revenue and Market Share by Manufacturer (2019-2024)
3.3 Global Efavirenz Industry Concentration Ratio (CR5 and HHI)
3.4 Top 5 Efavirenz Manufacturer Market Share
3.5 Top 10 Efavirenz Manufacturer Market Share
3.6 Date of Key Manufacturers Enter into Efavirenz Market
3.7 Key Manufacturers Efavirenz Key Manufacturers
3.8 Mergers & Acquisitions Planning
4 Analysis of Efavirenz Industry Key Manufacturers
4.1 Gilead Sciences
4.1.1 Compan Detail
4.1.2 Gilead Sciences Efavirenz Product Introduction, Application and Specification
4.1.3 Gilead Sciences 136 Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.1.4 Main Business Overview
4.1.5 Gilead Sciences News
4.2 Cipla
4.2.1 Compan Detail
4.2.2 Cipla Efavirenz Product Introduction, Application and Specification
4.2.3 Cipla Efavirenz Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.2.4 Main Business Overview
4.2.5 Gilead Sciences News
4.3 Emcure Pharmaceuticals
4.3.1 Compan Detail
4.3.2 Emcure Pharmaceuticals Efavirenz Product Introduction, Application and Specification
4.3.3 Emcure Pharmaceuticals Efavirenz Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.3.4 Main Business Overview
4.3.5 Emcure Pharmaceuticals News
4.4 Mylan Pharmaceuticals
4.4.1 Compan Detail
4.4.2 Mylan Pharmaceuticals Efavirenz Product Introduction, Application and Specification
4.4.3 Mylan Pharmaceuticals Efavirenz Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.4.4 Main Business Overview
4.4.5 Mylan Pharmaceuticals News
4.5 Sun Pharmaceutical Industries
4.5.1 Compan Detail
4.5.2 Mylan Pharmaceuticals Efavirenz Product Introduction, Application and Specification
4.5.3 Sun Pharmaceutical Industries Efavirenz Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.5.4 Main Business Overview
4.5.5 Sun Pharmaceutical Industries News
4.6 Veritaz Healthcare
4.6.1 Compan Detail
4.6.2 Veritaz Healthcare Efavirenz Product Introduction, Application and Specification
4.6.3 Veritaz Healthcare Efavirenz Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.6.4 Main Business Overview
4.6.5 Veritaz Healthcare News
4.7 Alkem Laboratories
4.7.1 Compan Detail
4.7.2 Alkem Laboratories Efavirenz Product Introduction, Application and Specification
4.7.3 Alkem Laboratories Efavirenz Sales, Price, Cost, Gross Margin, and Revenue (2019-2024)
4.7.4 Main Business Overview
4.7.4 Main Business Overview
5 Global Efavirenz Market Segment by Big Type
5.1 Global Efavirenz Revenue, Sales and Market Share by Big Type (2019-2024)
5.1.1 Global Efavirenz Sales and Market Share by Big Type (2019-2024)
5.1.2 Global Efavirenz Revenue and Market Share by Big Type (2019-2024)
5.2 10 Tables Sales Growth Rate and Price
5.2.1 Global 10 Tables Sales Growth Rate (2019-2024)
5.2.2 Global 10 Tables Price (2019-2024)
5.3 30 Tables Sales Growth Rate and Price
5.3.1 Global 30 Tables Sales Growth Rate (2019-2024)
5.3.2 Global 30 Tables Price (2019-2024)
6 Global Efavirenz Market Segment by Big Application
6.1 Global Efavirenz Sales Market Share by Big Application (2019-2024)
6.2 Hospital Sales Growth Rate (2019-2024)
6.3 Clinic Sales Growth Rate (2019-2024)
6.4 Drug Center Sales Growth Rate (2019-2024)
6.5 Other Sales Growth Rate (2019-2024)
7 Global Efavirenz Forecast
7.1 Global Efavirenz Revenue, Sales and Growth Rate (2024-2029)
7.2 Efavirenz Market Forecast by Regions (2024-2029)
7.2.1 North America Efavirenz Market Forecast (2024-2029)
7.2.2 Europe Efavirenz Market Forecast (2024-2029)
7.2.3 China Efavirenz Market Forecast (2024-2029)
7.2.4 Japan Efavirenz Market Forecast (2024-2029)
7.2.5 Southeast Asia Efavirenz Market Forecast (2024-2029)
7.2.6 Other Regions Efavirenz Market Forecast (2024-2029)
7.3 Efavirenz Market Forecast by Type (2024-2029)
7.3.1 Global Efavirenz Sales Forecast by Type (2024-2029)
7.3.2 Global Efavirenz Market Share Forecast by Type (2024-2029)
7.4 Efavirenz Market Forecast by Application (2024-2029)
7.4.1 Global Efavirenz Sales Forecast by Application (2024-2029)
7.4.2 Global Efavirenz Market Share Forecast by Application (2024-2029)
8 Market Analysis
8.1.1 Market Overview
8.1.2 Market Opportunities
8.1.3 Market Risk
8.1.4 Market Driving Force
8.1.5 Porter's Five Forces Analysis
8.1.6 SWOT Analysis
9 Efavirenz Related Market Analysis
9.1 Upstream Analysis
9.1.1 Macro Analysis of Upstream Markets
9.1.2 Key Players in Upstream Markets
9.1.3 Upstream Market Trend Analysis
9.1.4 Efavirenz Manufacturing Cost Analysis
9.2 Downstream Market Analysis
9.2.1 Macro Analysis of Down Markets
9.2.2 Key Players in Down Markets
9.2.3 Downstream Market Trend Analysis
9.2.4 Sales Channel, Distributors, Traders and Dealers
10 Research Findings and Conclusion
Tables & Figures:
List of Tables and Figures
Figure Product Picture Efavirenz
Figure Market Concentration Ratio and Market Maturity Analysis of Efavirenz
Figure Bottom-up and Top-down Approaches for This Report
Figure Part of Our External Database
Figure Part of Our External Database
Figure Key Executives Interviewed
Table Global Efavirenz Market Size by Big Type
Figure Global Market Share of Efavirenz by Big Type in 2023
Figure 10 Tables Picture (2019-2024)
Global Efavirenz Market Size by Big Application
Table Global Efavirenz Market Size by Application
Figure Global Efavirenz Market Share by Big Application in 2023
Figure Hospital Picture
Figure Clinic Picture
Figure Drug Center Picture
Figure Other Picture
Table Global Efavirenz Comparison by Regions (M USD) （2019-2029）
Figure Global Efavirenz Market Size (Million US$) (2019-2029)
Figure North America Efavirenz Revenue (Million US$) Growth Rate (2019-2029)
Figure Europe Efavirenz Revenue (Million US$) Growth Rate (2019-2029)
Figure China Efavirenz Revenue (Million US$) Growth Rate (2019-2029)
Figure Japan Efavirenz Revenue (Million US$) Growth Rate (2019-2029)
Figure Southeast Asia Efavirenz Revenue (Million US$) Growth Rate (2019-2029)
Table Business Impact Assessment - Covid-19
Table Market Trends and Efavirenz Potential Opportunities in the COVID-19 Landscape
Table Measures / Proposal against Covid-19
Table Global Efavirenz Sales by Manufacturer (2019-2024)
Figure Global Efavirenz Sales Market Share by Manufacturer in 2023
Table Global Efavirenz Revenue by Manufacturer (2019-2024)
Figure Global Efavirenz Revenue Market Share by Manufacturer in 2023
Table Global Efavirenz Manufacturers Market Concentration Ratio (CR5 and HHI)
Figure Top 5 Efavirenz Manufacturer (Revenue) Market Share in 2023
Figure Top 10 Efavirenz Manufacturer (Revenue) Market Share in 2023
Table Date of Key Manufacturers Enter into Efavirenz Market
Table Key Manufacturers Efavirenz Product Type
Table Mergers & Acquisitions Planning
Table Gilead Sciences Company Profile
Table Efavirenz Product Introduction, Application and Specification of Gilead Sciences
Table Efavirenz Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company One 2019-2024
Table Company One Main Business
Table Company One Recent Development
Table Cipla Company Profile
Table Efavirenz Product Introduction, Application and Specification of Cipla
Table Efavirenz Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2019-2024
Table Cipla Recent Development
Table Emcure Pharmaceuticals Company Profile
Table Efavirenz Product Introduction, Application and Specification of Emcure Pharmaceuticals
Table Efavirenz Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2019-2024
Table Emcure Pharmaceuticals Main Business
Table Emcure Pharmaceuticals Recent Development
Table Mylan Pharmaceuticals Company Profile
Table Efavirenz Product Introduction, Application and Specification of Mylan Pharmaceuticals
Table Efavirenz Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2019-2024
Table Mylan Pharmaceuticals Main Business
Table Mylan Pharmaceuticals Recent Development
Table Mylan Pharmaceuticals Main Business
Table Mylan Pharmaceuticals Recent Development
Table Sun Pharmaceutical Industries Company Profile
Table Efavirenz Product Introduction, Application and Specification of Sun Pharmaceutical Industries
Table Efavirenz Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2019-2024
Table Sun Pharmaceutical Industries Main Business
Table Sun Pharmaceutical Industries Recent Development
Table Veritaz Healthcare Company Profile
Table Efavirenz Product Introduction, Application and Specification of Veritaz Healthcare
Table Efavirenz Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2019-2024
Table Veritaz Healthcare Main Business
Table Veritaz Healthcare Recent Development
Table Alkem Laboratories Company Profile
Table Efavirenz Product Introduction, Application and Specification of Alkem Laboratories
Table Efavirenz Sales (K Unit), Price (USD/Unit), Revenue (M USD) and Gross Margin of Company Two 2019-2024
Table Alkem Laboratories Main Business
Table Alkem Laboratories Recent Development
Figure Global Efavirenz Sales and Growth Rate (2019-2024)
Figure Global Efavirenz Revenue and Growth Rate (2019-2024)
Table Global Efavirenz Sales by Regions (2019-2024)
Figure Global Efavirenz Sales Market Share by Regions in 2023
Table Global Efavirenz Revenue by Regions (2019-2024)
Figure Global Efavirenz Revenue Market Share by Regions in 2023
Figure North America Efavirenz Sales and Growth Rate (2019-2024)
Figure Europe Efavirenz Sales and Growth Rate (2019-2024)
Figure China Efavirenz Sales and Growth Rate (2019-2024)
Figure Japan Efavirenz Sales and Growth Rate (2019-2024)
Figure Southeast Asia Efavirenz Sales and Growth Rate (2019-2024)
Figure Other Regions Efavirenz Sales and Growth Rate (2019-2024)
Table Global Efavirenz Sales by Big Type (2019-2024)
Table Global Efavirenz Sales Market Share by Big Type (2019-2024)
Figure Global Efavirenz Sales Market Share by Big Type in 2023
Table Global Efavirenz Revenue by Big Type (2019-2024)
Table Global Efavirenz Revenue Market Share by Big Type (2019-2024)
Table Global Efavirenz Revenue Market Share by Big Type in 2023
Figure Global 10 Tables Sales Growth Rate (2019-2024)
Figure Global 10 Tables Price (2019-2024)
Figure Global 30 Tables Sales Growth Rate (2019-2024)
Table Global Efavirenz Sales by Big Application (2019-2024)
Table Global Efavirenz Sales Market Share by Big Application (2019-2024)
Figure Global Efavirenz Sales Market Share by Big Application in 2023
Figure Global Hospital Sales Growth Rate (2019-2024)
Figure Global Clinic Sales Growth Rate (2019-2024)
Figure Global Drug Center Sales Growth Rate (2019-2024)
Figure Global Other Sales Growth Rate (2019-2024)
Figure Global Efavirenz Sales and Growth Rate (2024-2029)
Figure Global Efavirenz Revenue and Growth Rate (2024-2029)
Table Global Efavirenz Sales Forecast by Regions (2024-2029)
Table Global Efavirenz Market Share Forecast by Regions (2024-2029)
Figure North America Sales Efavirenz Market Forecast (2024-2029)
Figure Europe Sales Efavirenz Market Forecast (2024-2029)
Figure China Sales Efavirenz Market Forecast (2024-2029)
Figure Japan Sales Efavirenz Market Forecast (2024-2029)
Figure Southeast Asia Sales Efavirenz Market Forecast (2024-2029)
Figure Other Regions Sales Efavirenz Market Forecast (2024-2029)
Table Global Efavirenz Sales Forecast by Type (2024-2029)
Table Global Efavirenz Market Share Forecast by Type (2024-2029)
Table Global Efavirenz Sales Forecast by Application (2024-2029)
Table Global Efavirenz Market Share Forecast by Application (2024-2029)
Table Market Opportunities in Next Few Years
Table Market Risks Analysis
Table Market Drivers
Figure Porter's Five Forces Analysis
Table Macro Analysis of Upstream Markets
Table Key Players in Upstream Markets
Table Key Players of Upstream Markets
Table Key Raw Materials
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Efavirenz
Table Macro Analysis of Down Markets
Table Key Players in Down Markets
Table Key Players of Downstream Markets
Figure Sales Channel
Figure North America Efavirenz Sales (K Units) Growth Rate Forecast (2024-2029)
Figure North America Efavirenz Revenue (Million US$) Growth Rate Forecast (2024-2029)
Figure Europe Efavirenz Sales (K Units) Growth Rate Forecast (2024-2029)
Figure Europe Efavirenz Revenue (Million US$) Growth Rate Forecast (2024-2029)
Figure Japan Efavirenz Production (K Units) Growth Rate Forecast (2024-2029)
Figure Japan Efavirenz Revenue (Million US$) Growth Rate Forecast (2024-2029)
Figure China Efavirenz Production (K Units) Growth Rate Forecast (2024-2029)
Figure China Efavirenz Revenue (Million US$) Growth Rate Forecast (2024-2029)
Figure Methodology/Research Approach
Figure Market Size Estimation
Figure Author List
Research Methodology:
Global Efavirenz Market Size Estimation
To estimate market size and trends, we use a combination of top-down and bottom-up methods. This allows us to evaluate the market from various perspectives—by company, region, product type, and end users.
Our estimates are based on actual sales data, excluding any discounts. Segment breakdowns and market shares are calculated using weighted averages based on usage rates and average prices. Regional insights are determined by how widely a product or service is adopted in each area.
Key companies are identified through secondary sources like industry reports and company filings. We then verify revenue estimates and other key data points through primary research, including interviews with industry experts, company executives, and decision-makers.
We take into account all relevant factors that could influence the market and validate our findings with real-world input. Our final insights combine both qualitative and quantitative data to provide a well-rounded view. Please note, these estimates do not account for unexpected changes such as inflation, economic downturns, or policy shifts.
Data Source
Secondary Sources
This study draws on a wide range of secondary sources, including press releases, annual reports, non-profit organizations, industry associations, government agencies, and customs data. We also referred to reputable databases and directories such as Bloomberg, Wind Info, Hoovers, Factiva, Trading Economics, Statista, and others. Additional references include investor presentations, company filings (e.g., SEC), economic data, and documents from regulatory and industry bodies.
These sources were used to gather technical and market-focused insights, identify key players, analyze market segmentation and classification, and track major trends and developments across industries.
| Market Size |
|
|
| Market Position of Top Company |
|
|
| Qualitative Analysis |
|
|
Primary Sources
As part of our primary research, we interviewed a variety of stakeholders from both the supply and demand sides to gather valuable qualitative and quantitative insights.
On the supply side, we spoke with product manufacturers, competitors, industry experts, research institutions, distributors, traders, and raw material suppliers. On the demand side, we engaged with business leaders, marketing and sales heads, technology and innovation directors, supply chain executives, and end users across key organizations.
These conversations helped us better understand market segmentation, pricing, applications, leading players, supply chains, demand trends, industry outlook, and key market dynamics—including risks, opportunities, barriers, and strategic developments.
Key Data Information from Primary Sources
| Primary Sources | Parameters | Key Data |
| Market Segments(by Application, by Type) |
|
|
| Total Market |
|
|